<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3099">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04397666</url>
  </required_header>
  <id_info>
    <org_study_id>P20/09_COVEYES</org_study_id>
    <nct_id>NCT04397666</nct_id>
  </id_info>
  <brief_title>RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19</brief_title>
  <acronym>P20/09</acronym>
  <official_title>RT-PCR on Conjunctival Sample for the Detection of SARS-Cov-2 in Patients With Covid-19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Versailles Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Versailles Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the purpose of the study is to study the detection of SARS-Cov-2 virus in the conjunctiva of
      covid-19 patients and the presence or absence of conjunctivitis in these patients
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2020</start_date>
  <completion_date type="Anticipated">November 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 15, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the SARS-Cov-2 positivity rate in patients with Covid-19 with or without signs of conjunctivitis</measure>
    <time_frame>3 months</time_frame>
    <description>to assess the SARS-Cov-2 positivity rate in patients with Covid-19 with or without signs of conjunctivitis</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">68</enrollment>
  <condition>SARS-CoV Infection</condition>
  <condition>Pinkeye</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>conjunctival RT PCR</intervention_name>
    <description>conjunctival sample in covid-19 patients</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men and Women positive for SARS-Cov-2 on a RT-PCR test of a sample of respiratory
             airway

          -  Persons over 18 years of age

          -  patients of both sexes

          -  Member of a social security scheme

          -  Having signed the consent form

        Exclusion Criteria:

          -  Minors not emancipated, persons out of state to express their consent

          -  Participation in intervention research on Covid-19 involving experimental treatment

          -  History of chronic disease conjunctiva

          -  Patient with one of the one of the criteria of following gravity:

               1. EN &gt; or =30/min,

               2. Pao2/Fio2 = or &lt; 300,

               3. confusion and/or disorientation,

               4. hypotension (Tas90mmhg, requiring aggressive filling),

               5. need for a invasive ventilation,

               6. septic shock
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Edouard KOCH</last_name>
    <phone>01 39 63 90 60</phone>
    <email>ekoch@ch-versailles.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier de versailles</name>
      <address>
        <city>Le Chesnay</city>
        <zip>78390</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edouard KOCH</last_name>
      <phone>01 39 63 90 60</phone>
      <email>ekoch@ch-versailles.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>May 20, 2020</study_first_submitted>
  <study_first_submitted_qc>May 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2020</study_first_posted>
  <last_update_submitted>August 14, 2020</last_update_submitted>
  <last_update_submitted_qc>August 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Versailles Hospital</investigator_affiliation>
    <investigator_full_name>Edouard KOCH</investigator_full_name>
    <investigator_title>coordonator investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

